AbbVie · 11 hours ago
Head of Hematology Franchise, Pipeline Commercialization Strategy
AbbVie is dedicated to discovering and delivering innovative medicines that address serious health issues. The Head of Hematology Franchise will be responsible for developing strategies to enhance AbbVie's leadership in hematological malignancies and expand into adjacent areas, while collaborating with cross-functional teams to ensure commercial viability and effective pipeline management.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
Develop, champion and communicate vision and overall compelling strategy to all related stakeholder groups gaining commitment and support to guide portfolio prioritization, asset strategies and BD investments within hematological malignancies
Understand market, key segment value drivers, growth opportunities, target product profiles, product positioning and revenue potential for multiple Phase II+ assets/indications within the heme franchise to drive winning portfolio value proposition plans and strong P&L investment thesis
Defines and drives strategic value creation across lifecycle together with R&D and commercial cross-functional partners for AbbVie’s hematology portfolio, integrating diverse internal and external perspectives
Partners with the PCS VP to deliver optimal commercial strategies to maximize the value of each of the assets within the heme franchise, as well as an integrated portfolio approach within the franchise
Partner with Medical Affair and Health Impact (MHI), Early & Late Clinical Development, and Commercial Cross-functional leaders to develop scientific platforms and drive data generation to satisfy Global and Area requirements for target product labels and target product claims. Oversees development and delivery of the product Target Product Profiles (TPP) within heme franchise
Oversees development of business cases for governance endorsement
Identify new value generation for the franchise to unlock further opportunity. Drive innovative and novel ways to accelerate commercialization and maximize value for patients and the company for the franchise
Drive prioritization of key leverage points in the treatment process and develop behavioral objectives for each stakeholder group to define commercial strategy for the assets and for the entire franchise
Effective and transparent risk, opportunity and issue management at strategic and operational levels across the franchise
Initiate geo-strategy and indication prioritization within the franchise in partnership with R&D, Commercial cross-functional leaders, and Affiliates on formulating optimal reimbursement and access strategies to fully realize value of multiple assets
Establish a strong external network, with engagement and consultation with clinical experts
Exhibit clear and courageous leadership behavior and implement optimal program structures where appropriate to drive timely and effective decision making
Partnering with Investor Relations, together with PCS VP, upon request to develop and actively manage the external messages for the analyst community
Partnership & alliance management (where applicable) to drive maximum value of the partnership and to maintain compliance with the partnership agreement
As a people leader, coach and develop talent, set goals, succession plan, and execute performance management agenda to align people performance to business goals, business KPIs, and to maximize business opportunities. Act as talent magnet for PCS team internally and externally
Broaden AbbVie’s Oncology network and presence by building scientific, academic, KOL, payer, and patient advocacy relationships
Qualification
Required
Bachelor's degree required; advanced degree (MBA, Ph.D, or MD) preferred
10-15+ years of experience in the pharmaceutical industry in progressive commercial leadership roles in marketing and/or sales. Recency of commercial in-line operational experience is a must, and P&L ownership is preferred in US or other major markets
Oncology therapeutic experience is a must, with experience in Multiple Myeloma preferred
Demonstrated ability to influence and manage a complex set of internal and external stakeholders
Strong strategic marketing skills including the ability to develop commercial strategies based on a thorough and structured approach, pared with a strong scientific/clinical understanding
Strong financial and commercial acumen with thorough understanding of P&L drivers and the ability to develop appropriate investment and top-line sales forecasts that generate long-term value
Strong executive presence and leadership skills are imperative as this leader will present to senior leaders on a regular basis and serve as a role model in the organization
Demonstrated and consistent experience in successfully leading organizational change
Outstanding partnering skills and the ability to lead a multi-disciplinary team and drive commercial decisions in a highly matrixed organization to accomplish business goals
Proven track record of successful leadership, management and coaching of teams and individuals, and in having developed talent
Preferred
Advanced degree (MBA, Ph.D, or MD) preferred
Successful launch experienced preferred
Managed care experience preferred
Global experience preferred
Benefits
Paid time off (vacation, holidays, sick)
Medical/dental/vision insurance
401(k)
Short-term incentive programs
Long-term incentive programs
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
H1B Sponsorship
AbbVie has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Recent News
2025-12-31
Company data provided by crunchbase